Literature DB >> 14062223

ORAL PROPIONYL ERYTHROMYCIN IN TREATING EARLY SYPHILIS.

W J BROWN, W G SIMPSON, M B MOORE, E V PRICE, S WEINSTEIN.   

Abstract

Entities:  

Keywords:  ERYTHROMYCIN; SYPHILIS; SYPHILIS SERODIAGNOSIS

Mesh：

Substances：

Year:  1963        PMID： 14062223      PMCID： PMC1915315     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  4 in total

1.  Allergic hepatitis caused by propionyl erythromycin ester of lauryl sulfate.

Authors:  D F JOHNSON; W H HALL
Journal:  N Engl J Med       Date:  1961-12-14       Impact factor: 91.245

2.  Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate.

Authors:  M M ROBINSON
Journal:  Antibiot Chemother (Northfield)       Date:  1962-03

3.  Techniques in evaluation of rapid antisyphilitic therapy.

Authors:  A P ISKRANT; R W BOWMAN; J E DONOHUE
Journal:  Public Health Rep       Date:  1948-07-23       Impact factor: 2.792

4.  Erythromycin hepato-sensitivity: a preliminary report of two cases.

Authors:  M A MASEL
Journal:  Med J Aust       Date:  1962-04-14       Impact factor: 7.738
  4 in total
  5 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  EVALUATION OF RPR CARD TEST FOR SYPHILIS SCREENING IN FIELD INVESTIGATIONS.

Authors:  W J BROWN; J F DONOHUE; E V PRICE
Journal:  Public Health Rep       Date:  1964-06       Impact factor: 2.792

3.  Co-operative evaluation of treatment for early syphilis. Preliminary report with special reference to spectinomycin sulphate (actinospectacin).

Authors:  J B Lucas; E V Price
Journal:  Br J Vener Dis       Date:  1967-12

Review 4.  Current status of the treatment of syphilis.

Authors:  E Barrett-Connor
Journal:  West J Med       Date:  1975-01

Review 5.  Controversies in the use of antimicrobials for the prevention and treatment of Lyme disease.

Authors:  G P Wormser
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.